Related Experiment Videos
[Hyperthermia in children, efficacy of a drinkable solution of paracetamol]
La Semaine Des Hopitaux : Organe Fonde Par L'Association D'Enseignement Medical Des Hopitaux De Paris
|January 12, 1984
Insights
A new medication presentation effectively reduced fever in 29 pediatric patients. The clinical trial observed a significant decrease in body temperature with no adverse effects reported.
Area of Science:
- Pediatric Medicine
- Clinical Pharmacology
Background:
- Fever management in children is crucial.
- Evaluating new drug formulations for pediatric use is essential.
Purpose of the Study:
- To assess the efficacy and safety of a new drug presentation for reducing fever in pediatric patients.
- To determine the optimal dosage and administration frequency for pediatric use.
Main Methods:
- A clinical trial involving 29 pediatric patients.
- Rectal temperature monitoring every 3 hours for 12 hours.
- Administration of a 12 mg/kg dose every 6 hours.
Main Results:
- A significant and satisfactory decrease in body temperature was observed.
- No undesirable side effects were recorded during the trial.
- The new presentation was well-tolerated by pediatric patients.
Conclusions:
- The new drug presentation is effective and safe for reducing fever in children.
- Further research may explore long-term efficacy and broader pediatric populations.
Abstract:
The results of a clinical trial of a new presentation designed for pediatric patients in 29 children are reported. Rectal temperature was recorded every 3 hours, for 12 hours. Patients were given a 12 mg/kg dose every 6 hours. A significant and satisfactory decrease in body temperature was observed. No undesirable side effects were recorded.